LIVE Webinar: Clinical Trial MythBusters

What Is the Value of Diversity in Clinical Trials?

November 01, 2018



Download Guide (PDF)

An online audience of cancer patients and their care partners joined us virtually for a webcast to learn about the clinical trial process from experts.

We are also planning other online and in-person events. If you haven’t already, please sign up for email updates, so we can alert you when important and inspiring videos become available.


How Can Experts Overcome Language and Cultural Barriers to Increase Clinical Trial Participation?

How are researchers helping to improve participation by minorities in clinical trials? Watch as expert Dr. Richard Schilsky discusses language and cultural barriers.

Published:

Why Are Minorities Often Underrepresented in Clinical Trials?

How can ethnic minorities gain access to more clinical trials? Watch as clinical trial experts Dr. Richard Schilsky and Cecelia Mann share their perspectives.

Published:

CML Patient Story: A 20-Year Survivor Shares His Clinical Trial Experience

Meet CML patient advocate Mel Mann, the longest living #Gleevec survivor. Watch as he describes his clinical trial experience and how participation led to his 20+ year survival.

Published:

Clinical Trial MythBusters: What Is the Value of Diversity in Clinical Trials?

Is diversity, gender, age and ethnicity important in clinical trials? Mel Mann, a 20+ year CML survivor and a a highly respected leader in the field of clinical oncology weigh in.

Published:

Host & Guests
Host
Guests

Senior Vice President and Chief Medical Officer, ASCO


Patient Advocate, Longest Living #Gleevec Survivor



This is a Patient Empowerment Network program produced by Patient Power. We thank AbbVie, Inc., Astellas, Celgene Corporation, and Novartis for their support.

 


 

 

 

Patient Power
Patient Empowerment Network
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on March 14, 2019